Dianthus Therapeutics | MGTA - Pe Kurs-Gewinn

Aktienkurs
83.57
Täglich Wechseln
-3.59 -4.12%
Monatlich
5.19%
Jährlich
284.23%
Q2 Prognose
85.52




Pe Veränderung Datum
Akebia Therapeutics 1.63K 1.6K 2025-12
Celltrion 50.09 23.24 2025-09
Cspc Pharmaceutical 24.4 1.13 2025-12
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 66.5 5.69 2025-12
IQVIA Holdings 26.59 2.03 2025-12
Kangmei Pharma 3.15K 624.19 2025-06
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Moderna 27.22 14.51 2023-06
Neuren Pharmaceuticals 72.14 59.86 2025-12
Organigram Holdings 235 224.49 2025-09
Organon & Co 3.75 0.87 2025-12
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 17.41 29.74 2025-12
Qiagen NV 20.54 0.1 2025-12
Revvity 49.87 16.58 2025-12
Sartorius 43.44 84.64 2026-03
Sino Biopharmaceutical 17.03 0.89 2025-06
Tectonic Therapeutic 4.01 0.63 2024-03
Tilray 11.56 80.19 2025-09
Viatris 10.4 11.84 2025-09
Zealand Pharma A/S 5.13 0.16 2025-12
Zz Pientze Pharmaceu 49.04 4.33 2025-09